The FDA has updated safety labels for several bisphosphonate medications including Fosamax, Reclast, Actonel, Atelvia, Binosto, Fosamax Plus D, and ibandronate sodium (Boniva generic). These drugs are commonly used to treat or prevent osteoporosis by slowing bone loss.
The update expands warnings about “atypical” fractures — previously focused on the thigh bone — to include other bones. In some cases, fractures may happen with little or no trauma.
Watch for warning signs like new, dull pain in the thigh, hip, groin, or other areas in the days or weeks before a fracture. Risk may be higher if you’re taking glucocorticoids like prednisone.
🔗 Learn more and stay informed — read below + subscribe for medication safety updates.
https://medshadow.org/drug-updates-recalls/fda-side-effect-updates/osteoporosis-drugs-and-new-bone-fracture-risks/
#fda #healtheducation #medicationmadesimple
http://dlvr.it/TRhd7m
Medicine can help, heal, or harm us. MedShadow believes you deserve to know the difference. As the leading nonprofit publisher of unbiased, unbought health news and information, we will never accept any pharma money. We’re committed to help you make the right choices, delivering dependable guidance on using medicines safely and finding the right alternative care.
Subscribe to:
Post Comments (Atom)
An Expert Guide to Safer, Smarter, Supplement Use
On May 13th, MedShadow is hosting a live webinar with an integrative psychiatrist and a clinical pharmacist to answer the questions most sup...
-
Are your generics safe? https://medshadow.org/webinar-investigating-generic-drugs-mending-the-tattered-safety-net-of-the-fda/?utm_source=you...

No comments:
Post a Comment